DR. STEVEN EDWARD COUTRE, MD
Osteopathic Medicine at Blake Wilbur Dr, Palo Alto, CA

License number
California G66387
Category
Osteopathic Medicine
Type
Hematology
Address
Address
875 Blake Wilbur Dr, Palo Alto, CA 94304
Phone
(650) 723-6661

Professional information

Steven E Coutre Photo 1

Dr. Steven E Coutre, Palo Alto CA - MD (Doctor of Medicine)

Specialties:
Hematology
Address:
703 Welch Rd STE G1, Palo Alto 94304
(650) 736-1204 (Phone)
Stanford Clinical Cancer Center
875 Blake Wilbur Dr, Palo Alto 94304
(650) 498-6000 (Phone)
Certifications:
Hematology, 1994, Internal Medicine, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
703 Welch Rd STE G1, Palo Alto 94304
Stanford Clinical Cancer Center
875 Blake Wilbur Dr, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1986
Yale New Haven Hospital
Graduated: 1987
Graduated: 1989
Stanford University School Med
Graduated: 1992


Steven Edward Coutre Photo 2

Steven Edward Coutre, Palo Alto CA

Specialties:
Internal Medicine, Hematology, Hematology & Oncology, Hematology
Work:
Stanford Hospital and Clinics
875 Blake Wilbur Dr, Palo Alto, CA 94304 Stanford University
875 Blake Wilbur Dr, Stanford, CA 94305 Stanford Hospital and Clinics
300 Pasteur Dr, Palo Alto, CA 94304 Stanford Hospital and Clinics
300 Pasteur Dr, Stanford, CA 94305
Education:
Stanford University (1986)


Steven Edward Coutre Photo 3

Steven Edward Coutre, Palo Alto CA

Specialties:
Internist
Address:
875 Blake Wilbur Dr, Palo Alto, CA 94304
Education:
Stanford University, School of Medicine - Doctor of Medicine
Stanford Hospital & Clinics - Fellowship - Hematology
Yale New Haven Psychiatric Hospital - Residency - Internal Medicine


Steven Coutre Photo 4

New Use Of Staurosporine Derivatives

US Patent:
2013028, Oct 31, 2013
Filed:
Jun 27, 2013
Appl. No.:
13/929438
Inventors:
Steven Coutre - Stanford CA, US
International Classification:
C07D 498/16
US Classification:
51421108
Abstract:
This application relates to the use of staurosporines derivatives for the curative, palliative or prophylactic treatment of allergic rhinitis, allergic dermatitis, drug allergy or food allergy, angioedema, urticaria, sudden infant death syndrome, bronchopulmonary aspergillosis, multiple sclerosis, or mastocytosis; and to a method of treatment of warm-blooded animals in which a therapeutically effective dose of a compound of a Staurosporine Derivative is administered to a warm-blooded animal suffering from one of the diseases or conditions mentioned above.


Steven Coutre Photo 5

Pharmaceutical Uses Of Staurosporine Derivatives

US Patent:
2007029, Dec 27, 2007
Filed:
Jun 17, 2004
Appl. No.:
10/560669
Inventors:
Steven Coutre - Stanford CA, US
International Classification:
A61K 31/553, A61P 37/08, C07D 273/06
US Classification:
514211080, 540545000
Abstract:
This application relates to the use of staurosporines derivatives for the curative, palliative or prophylactic treatment of allergic rhinitis, allergic dermatitis, drug allergy or food allergy, angioedema, urticaria, sudden infant death syndrome, bronchopulmonary aspergillosis, multiple sclerosis, or mastocytosis; and to a method of treatment of warm-blooded animals in which a therapeutically effective dose of a compound of a Staurosporine Derivative is administered to a warm-blooded animal suffering from one of the diseases or conditions mentioned above.